Home | Articles
Published on:December 2017
Indian Journal of Pharmaceutical Education and Research, 2017; 51(4s):s601-s606
Original Article | doi:10.5530/ijper.51.4s.88

Comparative in-vivo Evaluation of Anti-Cancer Drugs Loaded Nanospheres

Authors and affiliation (s):

Prakash Katakam1, Phalguna Yadagiri2*

1Professorand Prinicipal SSS Indira college of Pharmacy, Sahayog Educational Campus, Vishnupuri, Nanded, Maharashtra, INDIA.

2Department of pharmaceutics Jyothismathi college of Pharmacy, Turkapally(V), Shameerpet(M), Medchal-Dist. Telangana-500078, INDIA.


Objectives: objective of present research was to formulate and evaluate nanospheres of selected anticancer drugs, viz., Capecitabine (CPN), Tamoxifen (TAM) and Doxorubicin (DXO). The adverse effects associated with anticancer drugs which include are bonemarrow depression, cardio toxicity, diarrhoea, nausea and vomiting, stomatitis and dermatitis. Materials and Methods: Drug loaded nanospheres of polycaprolactone-chitosan in various drug: polymer ratios, cross linked with Tripolyphosphate were prepared by double emulsion solvent evaporation and solvent diffusion methods. Male white New Zeeland Rabbits(weighing about 2500 gm) were selected as the animalmodel. The rabbits selected for the study had no medicationfor two weeks prior to the study. Results and Discussion: The parameters like AUC(0-24) of DXO nanospheres 2362.0 ng.h/mL, whereas DXO pure drug was 1956.5 ng.h/mL. AUC (0-24) of TAM nanospheres 5646.00 ng.h/mL. Whereas TAM unadulterated medication was 4786.30ng.h/mL. AUC (0-24) of CPN nanospheres 4927.40 ng.h/mL. Whereas CPN pure drug was 4027.5ng.h/mL. Conclusion: In vivo results showed a significant increase in the bioavailability of drugs from DXO6, CPN6 and TAM6 nanospheres when compared to those of the standard drugs. This enhanced bioavailability could be helpful in reducing the dose of DXO, CPN and TAM and also reduce their toxicities. This enhanced bioavailability could be helpful in reducing the dose and also reduce the toxicities of the selected drugs.

Key words: Doxorubicin, Tamoxifen, Capecitabine, Nanospheres, in vivo studies.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).


Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs